Particularities of clinical-functional characteristics of combination pathology - obstructive sleep apnea-hypopnea syndrome and bronchial asthma during the treatment with prolonged beta2-agonists

Y. I. Feschenko, L. A. Yashyna, M. A. Polyanska, G. V. Sidun, S. M. Moskalenko (Kiev, Ukraine)

Source: Annual Congress 2003 - Sleep related breathing disorders and other diseases
Session: Sleep related breathing disorders and other diseases
Session type: Thematic Poster Session
Number: 2961
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. I. Feschenko, L. A. Yashyna, M. A. Polyanska, G. V. Sidun, S. M. Moskalenko (Kiev, Ukraine). Particularities of clinical-functional characteristics of combination pathology - obstructive sleep apnea-hypopnea syndrome and bronchial asthma during the treatment with prolonged beta2-agonists. Eur Respir J 2003; 22: Suppl. 45, 2961

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


The use of systemic corticosteroids in children with obstructive sleep apnea syndrome
Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Year: 2019

The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006

Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Asthma control in patients with asthma / obstructive sleep apnea overlap syndrome
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021


The prevalance of bronchial hyperreactivity in patients with habitual snoring and obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 495s
Year: 2002

Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007



Treatment of concomitant obstructive sleep apnea/hypopnea syndrome in patients with persistent poorly controlled bronchial asthma - Real opportunity to improve asthma control
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010



Bronchial hyperresponsiveness and obesity in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009


The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011

Airway inflammation in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002

Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma?
Source: Eur Respir J 2012; 39: 1547-1549
Year: 2012


Influence of electrostimulation of pharyngeal and laryngeal muscles with application of prolonged beta-2 agonist on functional signs of obstructive sleep apnea syndrome in patients with obstructive sleep apnea syndrome combined with chronic obstructive
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003

Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome?
Source: Eur Respir J 2008; 31: 1381-1382
Year: 2008


Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Airway inflammation and cold airway hyperresponsiveness in bronchial asthma patients with obstructive sleep apnea hypopnea syndrome
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014


Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma
Source: International Congress 2019 – Asthma education: lifestyle and adolescence
Year: 2019

Effects of upper airway obstruction sites on polysomnographic parameters and clinical manifestations in patients with obstructive sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006

Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006